Strides Pharma Science Limited (Strides) announced that its step‐down wholly‐owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a definitive asset transfer and licensing agreement with Pharmaceutics International, Inc.(Pii) to acquire 18 ANDAs (Abbreviated New Drug Application) for the US market. With access to these products, Strides will significantly expand its niche offerings…